MyoKardia's IPO

MyoKardia raised a round of funding on October 29, 2015. Investors include Public.

MyoKardia is developing a precision medicine approach to treat patients with genetic heart disease. By combining leading-edge cardiovascular genetics with recent advances in heart muscle biochemistry,…

Articles about MyoKardia's IPO: